Download PDF
CC BY-NC-ND 4.0 · Indian Journal of Neurosurgery 2018; 07(02): 090-095
DOI: 10.1055/s-0038-1669479
Review Article
Thieme Medical and Scientific Publishers Private Ltd.

Complications and Avoidance in Neurointerventional Surgery

Girish Rajpal
1   Neurointerventional Surgery, Max Hospital, Delhi, India
,
Noufal Basheer
2   Neurosurgery, MIMS-ASTER, Kozhikode, Kerala, India
› Author Affiliations
Further Information

Publication History

Received: 31 May 2018

accepted after revision: 09 July 2018

Publication Date:
05 September 2018 (online)

   Permissions and Reprints

Abstract

Because neurointerventional surgery is a minimally invasive technique does not mean that it is qualified for complication-free procedures. Rather working about 2 m away from the three-dimensional (3D) target lesion and looking at two-dimensional (2D) images makes it one of the most complication-prone subspecialties. Advancement in hardwares, techniques, and technologies with continuous ability to learn and modify accordingly can only keep the complication rate low as compared with traditional vascular neurosurgery.

Keywords

complications - neurointervention - thromboembolism
 

  • References

  • 1 Ross IB, Dhillon GS. Complications of endovascular treatment of cerebral aneurysms. Surg Neurol 2005; 64 (01) 12-18 discussion 18–19
    CrossrefPubMedGoogle Scholar
  • 2 Pierot L, Spelle L, Vitry F. ATENA Investigators. Immediate clinical outcome of patients harboring unruptured intracranial aneurysms treated by endovascular approach: results of the ATENA study. Stroke 2008; 39 (09) 2497-2504
    CrossrefPubMedGoogle Scholar
  • 3 Wong JM, Ziewacz JE, Panchmatia JR. et al. Patterns in neurosurgical adverse events: endovascular neurosurgery. Neurosurg Focus 2012; 33 (05) E14 Review
    CrossrefPubMedGoogle Scholar
  • 4 Stone PA, Campbell JE. Complications related to femoral artery access for transcatheter procedures. Vasc Endovascular Surg 2012; 46 (08) 617-623
    CrossrefPubMedGoogle Scholar
  • 5 Spies JB, Berlin L. Complications of femoral artery puncture. AJR Am J Roentgenol 1998; 170 (01) 9-11
    CrossrefPubMedGoogle Scholar
  • 6 Bashir Q, Ishfaq A, Baig AA. Safety of diagnostic cerebral and spinal digital subtraction angiography in a developing country: a single-center experience. Interv Neurol 2018; 7 (01) (02) 99-109
    PubMedGoogle Scholar
  • 7 Wagenbach A, Saladino A, Daugherty WP, Cloft HJ, Kallmes DF, Lanzino G. Safety of early ambulation after diagnostic and therapeutic neuroendovascular procedures without use of closure devices. Neurosurgery 2010; 66 (03) 493-496 discussion 496–497
    CrossrefPubMedGoogle Scholar
  • 8 Rupp SB, Vogelzang RL, Nemcek Jr AA, Yungbluth MM. Relationship of the inguinal ligament to pelvic radiographic landmarks: anatomic correlation and its role in femoral arteriography. J Vasc Interv Radiol 1993; 4 (03) 409-413
    CrossrefPubMedGoogle Scholar
  • 9 Altin RS, Flicker S, Naidech HJ. Pseudoaneurysm and arteriovenous fistula after femoral artery catheterization: association with low femoral punctures. AJR Am J Roentgenol 1989; 152 (03) 629-631
    CrossrefPubMedGoogle Scholar
  • 10 Rapoport S, Sniderman KW, Morse SS, Proto MH, Ross GR. Pseudoaneurysm: a complication of faulty technique in femoral arterial puncture. Radiology 1985; 154 (02) 529-530
    CrossrefPubMedGoogle Scholar
  • 11 Huggins CE, Gillespie MJ, Tan WA. et al. A prospective randomized clinical trial of the use of fluoroscopy in obtaining femoral arterial access. J Invasive Cardiol 2009; 21 (03) 105-109
    PubMedGoogle Scholar
  • 12 Abu-Fadel MS, Sparling JM, Zacharias SJ. et al. Fluoroscopy vs. traditional guided femoral arterial access and the use of closure devices: a randomized controlled trial. Catheter Cardiovasc Interv 2009; 74 (04) 533-539
    CrossrefPubMedGoogle Scholar
  • 13 Dudeck O, Teichgraeber U, Podrabsky P, Lopez HaenninenE, Soerensen R, Ricke J. A randomized trial assessing the value of ultrasound-guided puncture of the femoral artery for interventional investigations. Int J Cardiovasc Imaging 2004; 20 (05) 363-368
    CrossrefPubMedGoogle Scholar
  • 14 Cilingiroglu M, Feldman T, Salinger MH, Levisay J, Turi ZG. Fluoroscopically-guided micropuncture femoral artery access for large-caliber sheath insertion. J Invasive Cardiol 2011; 23 (04) 157-161
    PubMedGoogle Scholar
  • 15 Bhat FA, Changal KH, Raina H, Tramboo NA, Rather HA. Transradial versus transfemoral approach for coronary angiography and angioplasty - A prospective, randomized comparison. BMC Cardiovasc Disord 2017; 17 (01) 23
    CrossrefPubMedGoogle Scholar
  • 16 Jones LE, Yang KH, Feldtman RW. et al. Safety and Efficacy of Arterial Closure Devices in an Office-Based Angiosuite. Ann Vasc Surg 2018; ••• S0890-5096 (18) 30270-X
    PubMedGoogle Scholar
  • 17 Lata K, Kaki A, Grines C, Blank N, Elder M, Schreiber T. Pre-close technique of percutaneous closure for delayed hemostasis of large-bore femoral sheaths. J Interv Cardiol. 2018
    PubMedGoogle Scholar
  • 18 Karaolanis G, Kostakis ID, Moris D, Palla VV, Moulakakis KG. Fascia suture technique and suture-mediated closure devices: systematic review. Int J Angiol 2018; 27 (01) 13-22
    Article in Thieme ConnectPubMedGoogle Scholar
  • 19 Pierot L, Rajpal G, Kadziolka K, Barbe C. The place for remodeling technique and stenting in the endovascular management of intracranial aneurysms: a single-center analysis from 2008 to 2010. Neuroradiology 2012; 54 (09) 973-979
    CrossrefPubMedGoogle Scholar
  • 20 Cognard C, Weill A, Castaings L, Rey A, Moret J. Intracranial berry aneurysms: angiographic and clinical results after endovascular treatment. Radiology 1998; 206 (02) 499-510
    CrossrefPubMedGoogle Scholar
  • 21 Song JK, Niimi Y, Fernandez PM. et al. Thrombus formation during intracranial aneurysm coil placement: treatment with intra-arterial abciximab. AJNR Am J Neuroradiol 2004; 25 (07) 1147-1153
    PubMedGoogle Scholar
  • 22 Mazighi M, Yadav JS, Abou-Chebl A. Durability of endovascular therapy for symptomatic intracranial atherosclerosis. Stroke 2008; 39 (06) 1766-1769
    CrossrefPubMedGoogle Scholar
  • 23 Saatci I, Geyik S, Yavuz K, Cekirge HS. Endovascular treatment of brain arteriovenous malformations with prolonged intranidal Onyx injection technique: long-term results in 350 consecutive patients with completed endovascular treatment course. J Neurosurg 2011; 115 (01) 78-88
    CrossrefPubMedGoogle Scholar
  • 24 Qureshi AI, Luft AR, Sharma M, Guterman LR, Hopkins LN. Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part II—clinical aspects and recommendations. Neurosurgery 2000; 46 (06) 1360-1375 discussion 1375–1376
    CrossrefPubMedGoogle Scholar
  • 25 Fiehler J, Ries T. Prevention and treatment of thromboembolism during endovascular aneurysm therapy. Klin Neuroradiol 2009; 19 (01) 73-81
    CrossrefPubMedGoogle Scholar
  • 26 Sedat J, Chau Y, Gaudart J, Sachet M, Beuil S, Lonjon M. Prasugrel versus clopidogrel in stent-assisted coil embolization of unruptured intracranial aneurysms. Interv Neuroradiol 2017; 23 (01) 52-59
    CrossrefPubMedGoogle Scholar
  • 27 Yamada NK, Cross III DT, Pilgram TK, Moran CJ, Derdeyn CP, Dacey Jr RG. Effect of antiplatelet therapy on thromboembolic complications of elective coil embolization of cerebral aneurysms. AJNR Am J Neuroradiol 2007; 28 (09) 1778-1782
    CrossrefPubMedGoogle Scholar
  • 28 Sedat J, Chau Y, Gaudard J, Suissa L, Lachaud S, Lonjon M. Administration of eptifibatide during endovascular treatment of ruptured cerebral aneurysms reduces the rate of thromboembolic events. Neuroradiology 2015; 57 (02) 197-203
    CrossrefPubMedGoogle Scholar
  • 29 Bruening R, Mueller-Schunk S, Morhard D. et al. Intraprocedural thrombus formation during coil placement in ruptured intracranial aneurysms: treatment with systemic application of the glycoprotein IIb/IIIa antagonist tirofiban. AJNR Am J Neuroradiol 2006; 27 (06) 1326-1331
    PubMedGoogle Scholar
  • 30 Ries T, Buhk JH, Kucinski T. et al. Intravenous administration of acetylsalicylic acid during endovascular treatment of cerebral aneurysms reduces the rate of thromboembolic events. Stroke 2006; 37 (07) 1816-1821
    CrossrefPubMedGoogle Scholar
  • 31 Morcos SK, Thomsen HS, Webb JA. Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR) Eur Radiol 1999; 9 (08) 1602-1613
    PubMedGoogle Scholar
  • 32 Lin J, Bonventre JV. Prevention of radiocontrast nephropathy. Curr Opin Nephrol Hypertens 2005; 14 (02) 105-110
    CrossrefPubMedGoogle Scholar
  • 33 Kelly AM, Dwamena B, Cronin P, Bernstein SJ, Carlos RC. Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Ann Intern Med 2008; 148 (04) 284-294
    PubMedGoogle Scholar
  • 34 Halliwell B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 1990; 186: 1-85
    PubMedGoogle Scholar
  • 35 Drager LF, Andrade L, Barros de ToledoJF, Laurindo FR, Machado CésarLA, Seguro AC. Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury. Nephrol Dial Transplant 2004; 19 (07) 1803-1807
    CrossrefPubMedGoogle Scholar
  • 36 Zoungas S, Ninomiya T, Huxley R. et al. Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy. Ann Intern Med 2009; 151 (09) 631-638
    CrossrefPubMedGoogle Scholar
  • 37 Zagler A, Azadpour M, Mercado C, Hennekens CH. N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials. Am Heart J 2006; 151 (01) 140-145
    CrossrefPubMedGoogle Scholar
  • 38 Webb JG, Pate GE, Humphries KH. et al. A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect. Am Heart J 2004; 148 (03) 422-429
    CrossrefPubMedGoogle Scholar
  • 39 Levy E, Koebbe CJ, Horowitz MB. et al. Rupture of intracranial aneurysms during endovascular coiling: management and outcomes. Neurosurgery 2001; 49 (04) 807-811 discussion 811–813
    PubMedGoogle Scholar
  • 40 Loh Y, Duckwiler GR. Onyx Trial Investigators. A prospective, multicenter, randomized trial of the Onyx liquid embolic system and N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations. Clinical article. J Neurosurg 2010; 113 (04) 733-741
    PubMedGoogle Scholar
  • 41 Elijovich L, Higashida RT, Lawton MT, Duckwiler G, Giannotta S, Johnston SC. Cerebral Aneurysm Rerupture After Treatment (CARAT) Investigators. Predictors and outcomes of intraprocedural rupture in patients treated for ruptured intracranial aneurysms: the CARAT study. Stroke 2008; 39 (05) 1501-1506
    CrossrefPubMedGoogle Scholar
  • 42 Park YK, Yi HJ, Choi KS, Lee YJ, Chun HJ. Intraprocedural Rupture During Endovascular Treatment of Intracranial Aneurysm: Clinical Results and Literature Review. World Neurosurg 2018; 114: e605-e615
    CrossrefPubMedGoogle Scholar
  • 43 Weber W, Kis B, Siekmann R, Kuehne D. Endovascular treatment of intracranial arteriovenous malformations with onyx: technical aspects. AJNR Am J Neuroradiol 2007; 28 (02) 371-377
    PubMedGoogle Scholar
  • 44 Wong JM, Ziewacz JE, Panchmatia JR. et al. Patterns in neurosurgical adverse events: endovascular neurosurgery. Neurosurg Focus 2012; 33 (05) E14
    CrossrefPubMedGoogle Scholar
  • 45 Ketteler ER, Brown KR. Radiation exposure in endovascular procedures. J Vasc Surg 2011; 53 (01) Suppl 35S-38S
    PubMedGoogle Scholar
  • 46 Valentin J. Avoidance of radiation injuries from medical interventional procedures. Ann ICRP 2000; 30 (02) 7-67
    CrossrefPubMedGoogle Scholar